A Phase Ib/II trial to test the safety and efficacy of vaccination with HPV16 E711-19 nanomer for the treatment of incurable HPV-16 related oropharyngeal, cervical and anal cancer in HLA-A*02 positive patients - Stand Up To Cancer

Blog

Posted October 11, 2019

A Phase Ib/II trial to test the safety and efficacy of vaccination with HPV16 E711-19 nanomer for the treatment of incurable HPV-16 related oropharyngeal, cervical and anal cancer in HLA-A*02 positive patients

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Please validate the captcha
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.